(Q38503363)

3 September 2017

Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synovium (English)

1 reference

3 September 2017

0 references

1 reference

1 reference

I Gutierrez-Roelens

1

1 reference

3 September 2017

C Galant

2

1 reference

3 September 2017

I Theate

3

1 reference

3 September 2017

R J Lories

4

1 reference

3 September 2017

P Durez

5

1 reference

3 September 2017

A Nzeusseu-Toukap

6

1 reference

3 September 2017

B Van den Eynde

7

1 reference

3 September 2017

F A Houssiau

8

1 reference

3 September 2017

B R Lauwerys

9

1 reference

3 September 2017

1 May 2011

1 reference

3 September 2017

Arthritis & Rheumatology

1 reference

3 September 2017

63

1 reference

3 September 2017

5

1 reference

3 September 2017

1246-1254

1 reference

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

3 September 2017

1 reference

Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial

21 January 2018

1 reference

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

21 January 2018

1 reference

B lymphocyte depletion therapy with rituximab in rheumatoid arthritis

21 January 2018

1 reference

Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.

21 January 2018

1 reference

Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis

21 January 2018

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

21 January 2018

1 reference

Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis.

21 January 2018

1 reference

Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis

21 January 2018

1 reference

DAVID: Database for Annotation, Visualization, and Integrated Discovery

21 January 2018

1 reference

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response

21 January 2018

1 reference

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.30292

1 reference

3 September 2017

1 reference